Combining Physostigmine with Meperidine for Sedation and Analgesia During Colonoscopy

Abstract

Background and Study Aim: Opiate or benzodiazepine drugs are often used during colonoscopy, but they are associated with respiratory depression and prolonged recovery. Physostigmine, a tertiary anticholinesterase agent, is known to enhance analgesia and to reverse the central nervous system depressant effects of these drugs. This study compared the effect of giving meperidine alone with the effect of giving meperidine in combination with physostigmine in patients who were undergoing complete colonoscopy.
Patients and Methods: A total of 44 outpatients undergoing elective colonoscopy were randomly assigned to receive analgesia with either meperidine 0.5 mg/kg intravenously (group 1, n = 24) or physostigmine 10 micrograms/kg intravenously, followed 5 minutes later by meperidine 0.5 mg/kg intravenously (group 2; n = 20). The patients were assessed with regard to oxygen saturation, hemodynamic changes, pain perception and sedation scores, readiness to go home, and adverse effects.
Results: The group 1 patients’ oxygen saturations consistently fell, both during the procedure and in the recovery period; in group 2, oxygen saturations remained stable throughout the procedure and recovery period (95.88 % ± 0.99 vs. 98.15 ± 0.99, P < 0.001). Patients in group 2 reported lower pain perception scores during the procedure (measured using a visual analog scale) than patients in group 1 (1.46 ± 0.31 vs. 1.75 ± 0.41; F _1,42 = 6.484, P < 0.015) and were less sedated during recovery (F _1,41 = 6.56, P < 0.015). No significant differences were found between the two groups with regard to heart rate or arterial blood pressure. All patients in group 2 were ready to go home after 25 minutes in the recovery area; three patients in group 1 were not ready to leave at 25 minutes and left the facility after 60 minutes. Four patients suffered from minor side effects of physostigmine (sweating and nausea).
Conclusions: Combining physostigmine with meperidine as preparatory treatment for patients undergoing colonoscopy prevents respiratory depression, improves analgesia, and shortens recovery time, with only mild side effects.

References

• 1 Jamieson J. Anesthesia and sedation in the endoscopy suite: influences and options?.  Curr Opin Anesthesiol. 1999;  12 417-423
• 2 Shipley R H, Butt J H, Farbry J E, Horowitz B. Psychological preparation for endoscopy: physiological and behavioral changes in patients with differing coping styles for stress.  Gastrointest Endosc. 1977;  24 9-13
• 3 Rembacken B J, Axon T R. The role of pethidine in sedation for colonoscopy.  Endoscopy. 1995;  27 244-247
• 4 Chokhavatia S, Nguyen L, Williams R. et al . Sedation and analgesia for gastrointestinal endoscopy.  Am J Gastroenterol. 1993;  88 393-396
• 5 O’Connor K W, Jones S. Oxygen desaturation is common and clinically underappreciated during elective endoscopic procedures.  Gastrointest Endosc. 1990;  36 S2-S4
• 6 Eckardet V F, Kanzler G, Schmitt T. et al . Complications and adverse effects of colonoscopy with selective sedation.  Gastrointest Endosc. 1999;  49 560-565
• 7 Patterson K W, Noonan N, Keeling N W. et al . Hypoxemia during outpatient gastrointestinal endoscopy: the effects of sedation and supplemental oxygen.  J Clin Anesth. 1995;  7 136-140
• 8 Practice guidelines for sedation and analgesia by non-anesthesiologists. A report by the American Society of Anesthesiologists Task Force on sedation and analgesia by non-anesthesiologists.  Anesthesiology. 1996;  84 459-471
• 9 Hart R, Classen M. Complications of diagnostic gastrointestinal endoscopy.  Endoscopy. 1990;  22 229-233
• 10 Iber F L, Livak A, Kruss D M. Apnea and cardiopulmonary arrest during and after endoscopy.  J Clin Gastroenterol. 1992;  14 109-113
• 11 Lydic R, Baghdoryan H A. Cholinergic contributions to the control of consciousness. In: Yaksh TL, Lynch C III, Zapole WM et al (eds) Anesthesia: biologic foundation. Philadelphia; Lippincott-Raven 1997: 33-450
• 12 Nemirovski A, Niv D. Cholinergic mechanisms and antinociception.  Curr Rev Pain. 1996;  1 10-22
• 13 Snir-Mor I, Weinstock M, Davidson J T, Bahar M. Physostigmine antagonized morphine-induced respiratory depression in human subjects.  Anesthesiology. 1983;  59 6-9
• 14 Craig B, Caldwell C B, Gross J B. Physostigmine reversal of midazolam-induced sedation.  Anesthesiology. 1982;  57 125-127
• 15 Meuret P, Backman S B, Bonhomme V. et al . Physostigmine reverses propofol-induced unconsciousness and attenuation of the auditory steady state response and bispectral index in human volunteers.  Anesthesiology. 2000;  93 708-717
• 16 Dripps R D, Lamont A, Eckenhoff J E. The role of anesthesia in surgical mortality.  JAMA. 1961;  178 261
• 17 Palmer T. Anticholinesterase agents. In: Gilman AG, Goodman LG, Gilman A (eds) The pharmacological basis of therapeutics. 6th edn. New York; Macmillan Publising Co. Inc 1980: 100-119
• 18 Brievik E K, Skoglund L A. Comparison of present pain intensity assessments on horizontally and vertically oriented visual analogue scales.  Methods Find Exp Clin Pharmacol. 1998;  20 719-724
• 19 Chung F. Discharge criteria: a new trend.  Can J Anaesth. 1995;  42 1056-1058
• 20 Rudner R, Jalowiecki P, Kawecki P. et al . Conscious analgesia/sedation with remifentanyl and propofol versus total intravenous anesthesia with fentanyl, midazolam, propofol for outpatient colonoscopy.  Gastrointest Endosc. 2003;  57 657-663
• 21 Lydic R, Keifer J C, Baghdoyan H A, Becker L. Microdialysis of the pontine reticular formation reveals inhibition of acetylcholine release by morphine.  Anesthesiology. 1993;  79 1003-1012
• 22 Takita K, Herlenious E, Yamamoto Y, Lindahl S G. Effects of neuroactive substances on morphine-induced respiratory depression: an in vitro study.  Brain Res. 2000;  24 201-205
• 23 Ge X Q, Xu P C, Bian C F. Relationship between morphine-induced respiratory depression and the cholinergic system of the respiratory center.  Yao Xue Xue Bao. 1990;  25 566-572
• 24 Berkenbosch A, Olievier C N, Wolsink J G. et al . Effects of morphine and physostigmine on ventilatory response to carbon dioxide.  Anesthesiology. 1994;  80 1303-1310
• 25 Hedner J, Kraiczi H, Peker Y, Murphy P. Reduction of sleep-disordered breathing after physostigmine.  Am J Respir Crit Care Med. 2003;  168 1246-1251
• 26 Sitaram N, Buchsbaum M S, Gillin J C. Physostigmine analgesia and somatosensory-evoked responses in man.  Eur J Pharmacol. 1977;  42 285-290
• 27 Weinstock M, Davidson J T, Schnieden R, Schnieden H. Effect of physostigmine on morphine-induced postoperative pain and somnolence.  Br J Anaesth. 1982;  54 429-433
• 28 Petersson J, Gordh T E, Hartvig P, Wiklund L. A double-blind trial of the analgesic properties of physostigmine in postoperative patients.  Acta Anaesthesiol Scand. 1986;  30 283-288
• 29 Patil C S, Kulkarni S K. The morphine-sparing effct of physostigmine.  Methods Find Exp Clin Pharmacol. 1999;  21 523-527
• 30 Gage H D, Gage J C, Tobin J R. et al . Morphine-induced spinal cholinergic activation: in vivo imaging with positron emission tomography.  Pain. 2001;  91 139-145
• 31 Beilin B, Nemirovsky A Y, Zeidel A. et al . Systemic physostigmine increases the antinociceptive effect of spinal morphine.  Pain. 1997;  70 217-221
• 32 Beilin B, Bessler H, Papismedov L. et al . Continuous physostigmine combined with morphine-based patient-controlled analgesia in the postoperative period.  Acta Anaesthesiol Scand. 2005;  49 78-84
• 33 Hartvig P, Lindstrom B, Pettersson E, Wiklund L. Reversal of postoperative somnolence using a two-rate infusion of physostigmine.  Acta Anaesthesiol Scand. 1989;  33 681-685
• 34 Buccafusco J J. The role of central cholinergic neurones in the regulation of blood pressure and in experimental hypertension.  Pharm Rev. 1996;  48 179-211
• 35 Rupreht J, Dworacek B. The central anticholinergic syndrome in the postoperative period. In: Nunn JF, Utting JE, Brown BR (eds) General Anaesthesia. 5th edn. London; Butterworth 1989: 1141-1148
• 36 Bright E, Roseveare C, Dalgleish D. et al . Patient-controlled sedation for colonoscopy: a randomized trial comparing patient-controlled administration of propofol and alfentanil with physician-administered midazolam and pethidine.  Endoscopy. 2003;  35 683-687
• 37 Blouin R T, Conard P E, Gross J B. Time course of ventilatory depression following induction dose of propofol and thiopental.  Anesthesiology. 1991;  75 940-944
• 38 Vohra A, Thomas A N, Harper N JN, Pollard B J. Non-invasive measurements of cardiac output during induction of anaesthesia and tracheal intubation: thiopentone and propofol compared.  Br J Anaesth. 1991;  67 64-68
• 39 Murdoch J AC, Grant S A, Kenny G NC. Safety of patient-maintained propofol sedation using a target-controlled system in healthy volunteers.  Br J Anaesth. 2000;  85 299-301
• 40 Fassoulaki A, Sarantropoulos C, Derveniotis C. Physostigmine increases the dose of propofol required to induce anaesthesia.  Can J Anaesth. 1997;  44 1148-1151